SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures)NQF 0083 (Additional) Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

NQF 0083 (Additional) Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measure: NQF 0083 (Additional Measure)

Measure Title:  Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measurement Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure who also have LVSD (LVEF < 40%) and who were prescribed beta-blocker therapy.

*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.

Quality Measure Documentation Workflow

Quality Measure Documentation Workflow

In Order for the Clinical Quality Measure report to generate, the following must be documented in the relevant patient's chart:

1.  The patient must be 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period.

2.  Patients must have a diagnosis of Heart Failure (HF) and LVSD documented in the Summary Active Problems or the Assessment field of the encounter using one of the following ICD codes:

402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9.

3.  Two documentation options:

(a) Documentation that beta blocker therapy was prescribed by entering one of the following SMARText codes into the Summary Interventions or encounter Plan field using "PQRIhfBB": G8450.

OR

(b) Documentation that beta blocker therapy was prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

Atenolol - d00004, Betapace - d00371, Betaxolol - d00176, Coreg - d03847, Propranolol - d00032, Inderide - d03261, Labetalol/Normodyne - d00016, Metoprolol - d00134, Nadolol - d00018, Pindolol - d00137, Acebutolol - d00128, Tenoretic - d03258, Bisoprolol - d00709.

 

 

Measure Calculation Details

Numerator Calculation:

The numerator for this measure is calculated based on the following:

1.  The number of patients in the denominator who have one of the following documented during the reporting period:

(a)  The following SMARText code documented in the Summary Interventions for or the encounter Plan field using "PQRIhfBB" to document that beta blocker therapy was prescribed:

  • G8450: LVEF abnormal and beta-blocker prescribed

The follow items will not increase the numerator:

  • G8395: LVEF >=40% systolic
  • G8396: LVEF not performed or documented
  • G8451: LVEF abnormal and beta-blocker not prescribed
  • G8452: LVEF abnormal and beta-blocker not prescribed - reason not otherwise specified

OR

(b)  Documentation that beta blocker therapy was prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

  • Atenolol: d00004
  • Betapace: d00371
  • Betaxolol: d00176
  • Coreg: d03847
  • Propranolol: d00032
  • Inderide: d03261
  • Labetalol/Normodyne: d00016
  • Metoprolol: d00134
  • Nadolol: d00018
  • Pindolol: d00137
  • Acebutolol: d00128
  • Tenoretic: d03258
  • Bisoprolol: d00709

Denominator:

The denominator for this measure is calculated based on the following:

1.  The number of patients who are 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period

2.  And have a diagnosis of Heart Failure in the Summary Active Problems field or encounter Assessment field documented using one of the following ICD9 codes:

  • 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9

 

Report Clinical Quality Measures to CMS/States

All of the items in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For more information on how to export the numerator, denominator, and percentage for each Clinical Quality measure, Click Here.

For more information on reporting clinical quality measures, Click Here.